Upgrade to SI Premium - Free Trial

AbCellera Biologics (ABCL) PT Raised to $15 at BMO Capital

August 11, 2026 7:44 AM
BMO Capital analyst Gary Nachman ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change